A Study of Reslizumab in Patients 12 Years of Age and Older With Severe Eosinophilic Asthma
Clinical trial NCT03052725 · TERMINATED
Trial details
- NCT number
- NCT03052725
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-10
- Primary completion
- 2018-02-22
- Enrollment
- 391
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.